MedPath

VNUS® ClosureFAST™ Ablation versus Laser for Varicose Veins

Completed
Conditions
Varicose veins
Circulatory System
Varicose veins of lower extremities
Registration Number
ISRCTN66818013
Lead Sponsor
Imperial College London (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
170
Inclusion Criteria

1. Adults aged over 18 years, either sex
2. Venous reflux of the great saphenous vein

Exclusion Criteria

1. Patients unfit for general anaesthesia
2. Current deep vein thrombosis
3. Previous venous surgery
4. Significant peripheral vascular disease/Ankle Brachial Blood Pressure Index (ABPI) less than 0.8

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Average pain score at day 3 and day 10 following the procedure measured using an ungraduated visual analogue score (VAS) 0 = no pain, 10 = worst pain imaginable for 10 days following the procedure.
Secondary Outcome Measures
NameTimeMethod
1. Use of analgesia, measured at 10 days<br>2. Improvement in quality of life using the Aberdeen Varicose Vein Questionnaire (AVVQ), the 12-item Short Form (SF-12) and the Specific Quality of Life and Outcome Response - Venous (SQOR-V) questionnaires pre-operatively and at 6 weeks post-intervention<br>3. Abolition of reflux at 6 months measured using colour duplex<br>4. Improvements in venous refill times using digitial photoplethysmography, measured at 6 weeks and 6 months<br>5. Clinical improvement measured using the CEAP, Venous Clinical Severity Score (VCSS) and Venous Disability Score (VDS), measured at 6 weeks and 6 months<br>6. Return to normal activities and or work<br>7. Complications, assessed throughout the duration of the patient participation (6 months)
© Copyright 2025. All Rights Reserved by MedPath